Menu

Inspiring Innovation, Leica Biosystems Introduces the Next-Gen BOND RX IHC, ISH and Emerging Tests Stainer

Jun 28, 2018
Leica Biosystems

Simplify your research in cancer biology and discover new approaches to diagnosis with the new BOND RX next generation research stainer by Leica Biosystems. The BOND RX system provides researchers with the ability to design their ideal protocol. With customization options across all protocol editing segments, the BOND RX enables greater flexibility when optimizing conditions for a variety of test types including IF, ISH, FISH, TUNEL, TSA, CTC, Multiplexing and other emerging tests. Geared toward expanding the user’s freedom to discover, the latest advances to the BOND RX include enhancements to improve the overall user experience. Coupled with an expansion to the system’s customization capabilities, researcher’s now have more options to explore their ideas. Primary Features of the new BOND RX include:

 • Protocol Customization Advancements
     o Customize your dewax options. Add or subtract as many dewax steps as needed.
     o Choose from six unique probe application and removal protocols. Select the protocol that best suits your probe.
     o Select your dispense type with a choice of 3 different reagent flow options.
• Reagent Visual Management Lighting System
     o Reagents are illuminated and provide clear visual alerts to users at a glance.
• New software version 6.0
     o New highly visual user interface with easy to identify iconography. 

“With science advancing at such a rapid rate, it is an exciting time to be supporting researchers as they seek to unlock the complexity of cancer biology and develop new approaches to diagnosis” said Colin White, PhD Global Vice President – Advanced Staining at Leica Biosystems. “The release of the next generation of BOND RX is an important milestone in providing our customers with broader experimental flexibility and improved usability”. Leica Biosystems has an open system across the workflow and an optimized product portfolio that offers you the reproducibility and flexibility you need to uncover critical details. Spend less time on manual tasks and more time innovating to find answers – helping you obtain the data needed to secure funding for that next breakthrough discovery. The new BOND RX automated researcher stainer, featuring enhanced usability and increased protocol editing flexibility is available in USA.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.